Clinical Trials Logo
NCT number NCT03496311
Study type Observational
Source Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Contact Thomas Langer, MD
Phone +390250320463
Email thomas.langer@unimi.it
Status Recruiting
Phase
Start date April 13, 2018
Completion date April 2019

Clinical Trial Summary

The third trimester of pregnancy is typically characterized by the development of a marked respiratory alkalosis. The possible role of pregnancy-induced variations of cerebrospinal fluid (CSF) acid-base characteristics on the development of hypocapnic alkalosis is still unknown.

Aim of this study is to characterize, according to Stewart's approach, the acid-base equilibrium of CSF and arterial plasma of pregnant women and compare the results with data obtained from fertile, non-pregnant women.


Clinical Trial Description

The reduction in plasma PCO2 correlates with gestational age and was shown to be associated to plasma progesterone concentrations. We hypothesize that pregnancy-related haemodilution, inducing a reduction in CSF Strong Ion Difference (SID), might have a role in the development of pregnancy-related hypocapnic alkalosis.

Samples of CSF and arterial plasma of pregnant women with gestational age > 35 weeks undergoing spinal anesthesia for elective caesarean section will be analyzed for blood gases, pH, electrolytes, osmolality, albumin and haemoglobin concentration. In addition plasma copeptin levels will be analyzed. The same measurements will be performed in fertile, non-pregnant women undergoing spinal anesthesia for elective surgery.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Completed NCT01200979 - Assessment of Alterations in Immune Function During Pregnancy and Post Parturition
Recruiting NCT03218956 - Protein Requirement During Lactation N/A
Active, not recruiting NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry N/A
Recruiting NCT03403543 - Chinese Pregnant Woman Cohort Study N/A
Not yet recruiting NCT03208179 - Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa Phase 3
Recruiting NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02909712 - Cardio‑Safety of Dihydroartemisinin‑Piperaquine and Pharmacokinetics of Piperaquine Amongst Pregnant Women in Tanzania Phase 2
Recruiting NCT02797327 - Molecular Signature Pregnancy N/A
Recruiting NCT02676882 - EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy N/A
Recruiting NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Not yet recruiting NCT02762773 - Effect of Non-Dissection of the Inferior Rectus Sheath on Intraoperative Blood Loss N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02277782 - Intrathecal Hydromorphone for Labor Analgesia N/A
Recruiting NCT02528136 - The Clinical Carbetocin Myocardium Trial Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer N/A
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Active, not recruiting NCT02537145 - PregnanT Moms Measure - Do-It-Yourself Health Monitoring and Simulation of Health in Pregnant Women N/A
Active, not recruiting NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3
Active, not recruiting NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy Phase 1
Completed NCT02520687 - Effects of Dietary Nitrate in Hypertensive Pregnant Women Phase 1